Akari Therapeutics Announces R&D Day on April 24, 2017

NEW YORK and LONDON, March 17th, 2017

— Presentation to Include New Coversin Phase II Data in PNH and Latest Data on Pipeline –

Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that it will hold a Research and Development Day on April 24, 2017 in New York. The event will be hosted by members of Akari’s executive leadership team and will feature presentations from investigators and independent scientific advisors.

Click here to see full release